HCA Healthcare (HCA) Expected to Announce Earnings on Tuesday

HCA Healthcare (NYSE:HCA) is expected to be issuing its Q4 2025 results before the market opens on Tuesday, January 27th. Analysts expect HCA Healthcare to post earnings of $7.37 per share and revenue of $19.6713 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Tuesday, January 27, 2026 at 10:00 AM ET.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same quarter in the prior year, the company earned $4.90 EPS. The firm’s revenue for the quarter was up 9.6% compared to the same quarter last year. On average, analysts expect HCA Healthcare to post $25 EPS for the current fiscal year and $28 EPS for the next fiscal year.

HCA Healthcare Stock Performance

Shares of HCA opened at $470.52 on Monday. The firm has a market cap of $107.37 billion, a PE ratio of 18.19, a price-to-earnings-growth ratio of 1.30 and a beta of 1.36. HCA Healthcare has a 52-week low of $295.00 and a 52-week high of $520.00. The business’s 50 day moving average price is $480.37 and its two-hundred day moving average price is $434.31.

Insider Activity at HCA Healthcare

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the firm’s stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 1.30% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On HCA Healthcare

Several institutional investors have recently modified their holdings of HCA. Palisade Asset Management LLC bought a new stake in HCA Healthcare during the third quarter worth $26,000. JPL Wealth Management LLC purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $33,000. Triumph Capital Management purchased a new position in shares of HCA Healthcare in the 3rd quarter worth about $51,000. Johnson Financial Group Inc. increased its holdings in HCA Healthcare by 55.7% during the third quarter. Johnson Financial Group Inc. now owns 358 shares of the company’s stock worth $153,000 after buying an additional 128 shares during the last quarter. Finally, MUFG Securities EMEA plc bought a new position in shares of HCA Healthcare during the 2nd quarter valued at approximately $196,000. 62.73% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several research analysts recently issued reports on HCA shares. Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. Truist Financial raised their target price on HCA Healthcare from $495.00 to $520.00 and gave the company a “buy” rating in a research note on Monday, January 5th. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Raymond James Financial set a $525.00 target price on HCA Healthcare in a research report on Monday, October 27th. Finally, Robert W. Baird boosted their price target on shares of HCA Healthcare from $423.00 to $450.00 and gave the company a “neutral” rating in a research note on Thursday, December 11th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, HCA Healthcare has a consensus rating of “Moderate Buy” and an average price target of $488.75.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.